The Bcl-2 homologous region 3 (BH3) is sucient for interaction of pro-apoptotic with anti-apoptotic Bcl-2 family members, and functional antagonism may determine whether cell survival or death is the outcome of this protein-protein interaction. To address the biological role of BH3, two Bax-Bcl2 chimeras were generated in which 13 amino acids encompassing BH3 was swapped between anti-apoptotic Bcl-2 and pro-apoptotic Bax, thereby generating Bax with BH3 of Bcl-2 (Bax-BH3Bcl2), and Bcl-2 with BH3 of Bax (Bcl2-BH3Bax). Function and binding of the chimeras was then assessed utilizing the adenoviral Bcl-2 homologue, E1B 19K, which blocks apoptosis, and interacts with Bax, but not with Bcl-2. E1B 19K did not interact with Bax-BH3Bcl2 but did interact with Bcl2-BH3Bax. Bax-BH3Bcl2 retained proapoptotic function, while Bcl2-BH3Bax did not exhibit either pro-or anti-apoptotic activity. Thus, BH3 of Bcl-2 encodes binding speci®city but not the apoptotic propensity. E1B 19K could not block Bax-BH3Bcl2-induced apoptosis, suggesting that E1B 19K may act to antagonize pro-apoptotic proteins rather than as an eector of survival. Furthermore, Bax expression disrupted the mitochondrial membrane potential, which could be rescued by E1B 19K expression. Thus, BH3 controls the binding speci®city among Bcl-2 family members, and direct interaction between pro-apoptotic and anti-apoptotic proteins is a mechanism to regulate mitochondrial membrane potential and apoptosis.
Introduction
Apoptosis is a genetically programmed cellular response to commit suicide, which plays a critical role in normal development, maintenance of homeostasis and occurrence of cancer (White, 1996; Yang and Korsmeyer, 1996) . This process leads to a series of speci®c morphological and biochemical events, consisting of mitochondrial depolarization, activation of caspases (a family of cysteine proteases), chromosomal DNA fragmentation, chromatin condensation, and cell shrinkage. Excessive induction of apoptosis can contribute to neurodegenerative disorders such as Alzheimer's disease and spinal muscular atrophy. Inappropriate inhibition of apoptosis, however, can lead to the development of cancer. Therefore, understanding the regulation of apoptosis would contribute signi®cantly to our concept of how these diseases occur.
A major advance in the study of apoptosis was the discovery of the Bcl-2 family members, de®ned by the presence of conserved domains, designated Bcl-2 homologous region 1, 2, 3, and 4 (BH1, BH2, BH3 and BH4) (Chiou et al., 1994b; Chittenden et al., 1995a; Han et al., 1996a; Huang et al., 1997; Yin et al., 1994) . Depending on their functions, Bcl-2 family members can be divided into two groups: antiapoptotic proteins (examples include Bcl-2, Bcl-x L , and E1B 19K of adenovirus) and pro-apoptotic proteins (examples include Bax, Bak and Nbk/Bik) (Boyd et al., 1995; Chittenden et al., 1995b; Han et al., 1996a; Oltvai et al., 1993) . A common feature of the regulation of apoptosis by Bcl-2 family members is protein-protein interactions between anti-apoptotic proteins and pro-apoptotic proteins (Oltvai et al., 1993) . Mutations in Bcl-2 that abrogate heterodimerization with Bax, for example, result in loss of the ability of Bcl-2 to suppress cell death (Yin et al., 1994) . Alternatively, deletion of BH3 in Bak causes loss of both the ability to interact with Bcl-2 and Bcl-x L , and to induce apoptosis, suggesting that Bak may need to bind to pro-survival proteins to induce apoptosis (Chittenden et al., 1995a) . This reciprocal antagonism between anti-apoptotic proteins and pro-apoptotic proteins has led to the hypothesis that the relative abundance of both sets of proteins is of critical importance in regulating apoptosis (Oltvai et al., 1993) . However, it remains unclear which are the eectors of either survival or death.
BH3 appears to be both necessary and sucient for the interaction of pro-apoptotic with anti-apoptotic proteins. Either a 29 amino acid segment of Bax or a 50 amino acid segment of Bak, both of which include BH3, is sucient to bind to Bcl-2, Bcl-x L , and E1B 19K (Chittenden et al., 1995a; Han et al., 1996a) . More signi®cantly, expression of the 50 amino acid segment of Bak is sucient to induce apoptosis, which suggests that BH3 of Bak may bind and antagonize the anti-apoptotic function of a Bcl-2-like protein (Chittenden et al., 1995a) . In support of this concept, a family of proteins containing only BH3, exempli®ed by Nbk/Bik, can interact with Bcl-2, Bcl-x L , and E1B 19K, and induce cell death (Boyd et al., 1995; Chittenden et al., 1995a; Han et al., 1996b) . Since Bcl-2 also possesses BH3, but does not induce cell death, its presence is not sucient to confer lethality, suggesting that the context of BH3 may determine whether a protein has apoptosis promoting activity. Surprisingly, insertion of amino acid residues 55 ± 77 of Bax, which contains BH3 in place of the corresponding sequence in amino acid residues 78 ± 115 of Bcl-2, converts Bcl-2 from a death-suppressing to a death-inducing molecule (Hunter and Parslow, 1996) . These data indicate that BH3 of the proapoptotic is sucient to interact with anti-apoptotic Bcl-2 family members but may also encode an eector activity for inducing apoptosis.
The structural studies of Bcl-x L show that the arrangement of the a helixes in Bcl-x L is similar to the membrane translocation domain of bacterial toxins (Muchmore et al., 1996) . Furthermore, Bcl-x L localizes to the outer membrane of mitochondria (GonzalezGarcia et al., 1994; Wolter et al., 1997) . These observations suggest that Bcl-x L could aect mitochondrial function by aecting the membrane potential of mitochondria (Vander Heiden et al., 1997) . It has been shown that cytochrome c is released from the mitochondria during the apoptotic process and it is required as a cofactor for Apaf-1 function (Liu et al., 1996; Zou et al., 1997) . Apaf-1, a mammalian homologue of the C. elegans CED-4, forms a complex with caspase-9 in the presence of cytochrome c and dATP, which leads to caspase-9 activation which in turn activates caspase-3 (Li et al., 1997; Zou et al., 1997) . However, overexpression of Bcl-2 or Bcl-x L prevents the release of cytochrome c from the mitochondria leading to a block in the initiation of apoptosis (Kharbanda et al., 1997; Kim et al., 1997; Kluck et al., 1997; Yang et al., 1997) . Taken together, these observations suggest that mitochondria are a component in the apoptotic cascade, which are regulated by the Bcl-2 family members.
The structural analysis of Bcl-x L demonstrates that BH3 of Bcl-x L resides within the a-helix 2 (Muchmore et al., 1996) . It has been reported that 16 amino acids within the a-helix 2 of human Bak (72 ± 87) was sucient to bind to Bcl-x L (Sattler et al., 1997) . Accordingly, human Bax 57 ± 72, which corresponds to the 16 amino acids of hBak (72 ± 87) and contains BH3, was sucient to interact with Bcl-x L (Sattler et al., 1997) . Creation of individual missense mutation in Val74, Ile78, Ile81 and Ile85 to Ala in hBak resulted in dramatic reduction of the binding anity with hBcl-x L . Thus, these amino acids make up the hydrophobic surface of the a-helix 2 and contribute to the interaction with other Bcl-2 family members (Sattler et al., 1997) .
The E1B 19K protein, an adenoviral version of Bcl-2 family, interacts with part of exon 3 of Bax which encodes only 29 amino acids and contains BH3 (Han et al., 1996a) . Although BH3 is conserved in Bcl-2, E1B 19K does not interact with Bcl-2, suggesting that despite the high degree of conservation, BH3 of Bax possesses a dierent binding speci®city than BH3 of Bcl-2. To address the binding and functional speci®city of BH3, two Bax-Bcl2 chimeras were generated, in which the 13 amino acids encoding Figure 1 Mapping of the minimal region of rBax required for the interaction with E1B 19K and hBcl-2. Two-hybrid interaction assays were performed in the yeast strain YGH1 using His3 and lacZ reporters under the control of gal4 operators. Protein-protein interactions were evaluated between the plasmids expressing the GAL4 activation domain fused to a series of deletion mutants of the 29 amino acids region of rBax, and the plasmids expressing a GAL4 DNA binding domain (pGBT-9) fused to either the E1B 19K protein or hBcl-2. The +Histidine plates lack only leucine and tryptophan, thus selecting for the presence of pGAD-GH and pGBT-9. The 7Histidine plates lack leucine, tryptopan, and histidine thus selecting not only for the presence of the two plasmids but also for the interaction of the plasmid-encoded fusion proteins. Bracket marked minimal binding region indicates that it interacts with E1B 19K and hBcl-2, which contains rBax 54-74. Bracket a helix 2 indicates the location of the second a-helix in rBax, which is predicted from the structure of Bcl-x L (Muchmore et al., 1996) . The hydrophobic side of a-helix 2 is in bold and underlined. Bracket BH3 indicates BH3 in rBax. The swapped region represents the region exchanged for generating Bax-Bcl2 chimeras. Strong interaction is indicated by (+++) and no interaction is indicated by (7) BH3 was exchanged between Bax and Bcl-2. Using these two Bax-Bcl2 chimeras, we showed that BH3 likely controls the speci®city of these protein-protein interactions, but not the eector activity, which regulates cell viability by maintaining mitochondrial membrane integrity.
Results

Minimal region of Bax sucient for interaction with E1B 19K and Bcl-2
We have demonstrated previously that rBax 50 ± 78, a 29 amino acid region of rat Bax (rBax), which includes BH3, is sucient to interact with the E1B 19K and hBcl-2 proteins in yeast (Figure 1 ) (Han et al., 1996a) . A series of deletion mutants of the region of rBax were constructed in the pGAD yeast vector, to determine the minimal binding region sucient to interact with E1B 19K and hBcl-2. Most overlaying segments spanning this region did not display interaction with either E1B 19K or Bcl-2 (Figure 1 ). Only fragments containing amino acid residues 50 ± 74 or 54 ± 78 of rBax showed strong interaction with E1B 19K and hBcl-2 in yeast ( Figure 1 ). This implied that the minimal binding region of rBax lay within amino acids 54 ± 74. Cutting this region in half (rBax 54 ± 66 and rBax 63 ± 75) did not permit interaction with E1B 19K and hBcl-2 (Figure 1 ). Therefore, rBax 54 ± 74, which contains BH3, is comprised of minimal binding region to interact with E1B 19K and hBcl-2, which suggests that E1B 19K and Bcl-2 binding sequences in rBax are probably very similar, if not identical.
rBax 54 ± 74 corresponds to a-helix 2 which contains BH3 of Bcl-2 (Figure 1 ). Amino acids Leu59, Leu63, Ile66 and Leu70 of rBax ( Figure 1 , bold and underlined type), which correspond to Val74, Ile78, Ile81 and Ile85 of hBak, likely comprise the hydrophobic surface of the a-helix 2, contributing to the binding of rBax to E1B 19K and hBcl-2. Therefore, binding assays in combination with structural studies indicate that a-helix 2 forms a hydrophobic surface for interaction of pro-apoptotic Bax or Bak with antiapoptotic Bcl-2, Bcl-x L , and E1B 19K.
Generation of BH3 chimeras
The similarity of BH3 and its surrounding amino acids was assessed by amino acid sequence alignment among Bcl-2 family members ( Figure 2a ). BH3 is highly conserved and amino acids downstream of BH3 are also conserved, whereas upstream amino acid sequences did not show high homology except the presence of hydrophobic Val and Leu (Figure 2a) . To address the relationship between binding speci®city and function in BH3, we swapped BH3 between Bcl-2 and Bax. BH3 of rBax was replaced with BH3 of hBcl-2 (rBax-BH3Bcl2) and BH3 of hBcl-2 was replaced with BH3 of rBax (hBcl2-BH3Bax) (Figure 2b ). To avoid gross alteration in the structure of the chimeric proteins, we exchanged only the homologous region containing 13 amino acids encoding Bcl-2 97 ± 109 and Bax 63 ± 75.
Binding ability of rBax-BH3Bcl2 and hBcl2-BH3Bax chimeras with Bcl-2 family members
To characterize the binding ability of the Bax-Bcl2 chimeras with other Bcl-2 family members, we performed yeast two-hybrid assays. Wild-type rBax interacted with death-suppressers, hBcl-2 and E1B 19K, while it did not interact with the death-inducer, human Nbk/Bik (Figure 3 ). The rBax-BH3Bcl2 protein bound to Bcl-2 but not E1B 19K. Since hBcl-2 does not interact with E1B 19K (Han et al., 1996a) and rBax-BH3Bcl2 had BH3 of hBcl-2, it was expected if BH3 encoded binding speci®city, that rBaxBH3Bcl2 would not interact with E1B 19K. It has been shown that rBax can homodimerize in vivo (Oltvai et al., 1993) . However, rBax is toxic in yeast and when both pGBT-9-rBax and pGAD-rBax were cotransfected, few colonies grew on nonselective+histidine plates. Therefore, it was not possible to detect the homodimerization of rBax in yeast. Wild-type hBcl-2 homo-dimerizes and also heterodimerizes with rBax and hNbk, but it does not interact with E1B 19K (Boyd et al., 1995; Han et al., 1996a,b; Oltvai et al., 1993) . hBcl2-BH3Bax, however, interacted with E1B 19K, while it did not bind to hBcl-2, rBax and hNbk (Figure 3 ).
In parallel with the yeast two-hybrid assay for the interaction of the Bax-Bcl2 chimeras, we con®rmed the binding speci®city by employing a Glutathione-STransferase (GST) fusion protein system. GST alone, GST-19K, and GST-hBcl-2 which did not contain the transmembrane region of hBcl-2 (13 amino acids), were immobilized onto glutathione sepharose beads and puri®ed (Figure 4a ). Equal amounts of the GST-fusion proteins (3 mg) were incubated with in vitro translated rBax, hBcl-2, rBax-BH3Bcl2 and hBcl2-BH3Bax proteins. rBax did not bind to GST alone, but bound to (Figure 4b ). In contrast, rBax-BH3Bcl2 did not associate with either or GST alone, in agreement with the binding speci®city in yeast. hBcl-2 interacted with GST-hBcl-2, but not with GST alone and GST-19K (Figure 3c ). However, hBcl2-BH3Bax speci®cally bound to GST-19K, but not GST alone and GST-hBcl-2. Therefore, the binding A possible explanation for altered binding speci®city of hBcl2-BH3Bax is that BH3 of rBax is the binding site for E1B 19K, allowing interaction of E1B 19K with hBcl2-BH3Bax. The binding of hBcl2-BH3Bax to Bcl-2, Bax, and Nbk may be more complex or the insertion of BH3 of Bax may disrupt the folding of hBcl2-BH3Bax. By replacing BH3 of Bax with that of Bcl-2, we altered the speci®city of Bax such that it no longer bound to E1B 19K, but retained Bcl-2 interaction. Thus, the binding speci®city re¯ected that of Bcl-2 rather than Bax. Therefore, E1B 19K does not bind to rBax-BH3Bcl2 but to hBcl2-BH3Bax, and the nature of BH3 appears to determine binding speci®city between Bax and Bcl-2 with E1B 19K.
Intracellular localization of rBax-BH3Bcl2 and hBcl2-BH3Bax
To determine the localization of the rBax-BH3Bcl2 and hBcl2-BH3Bax proteins, indirect immunofluorescence was performed. The 4B cell line, which is an E1A plus tsp53 (val135) transformed baby rat kidney (BRK) cell line that stably expresses hBcl-2 (Chiou et al., 1994a) , was transfected with pcDNA3-Myc-rBax, pcDNA3-Myc-rBax-BH3Bcl2, pcDNA3-Myc-hBcl-2, or pcDNA3-Myc-hBcl2-BH3Bax plasmids to assess intracellular localization ( Figure 5 ) and function. The transfected cells were ®xed 16 h post-transfection and stained with an anti-Myc monoclonal antibody to detect the ectopically expressed proteins. The localization of the rBax-BH3Bcl2 appeared largely similar to that of wild-type rBax, which localized to cytoplasmic, perinuclear membranes, typi®ed by punctate cytoplasmic staining (Figure 5a and b), which resembles the staining pattern of mitochondria. hBcl2-BH3Bax showed a slightly dierent pattern from wild-type hBcl-2. Although hBcl2-BH3Bax displayed perinuclear membrane staining similar to Bcl-2, the punctate pattern in cytoplasm appeared larger than wild-type hBcl-2 (Figure 5c and d). Thus, exchanging the BH3 region between rBax and hBcl-2 profoundly altered the binding speci®city but did not dramatically aect the intracellular distribution of the proteins.
rBax-BH3Bcl2 induces cell death
To determine the functional activity of the two BaxBcl2 chimeras, pcDNA3-Myc-rBax-BH3Bcl2 and pcDNA3-Myc-hBcl2-BH3Bax were cotransfected with pCMV b-gal expressing b-galactosidase into the p53A cell line, which was derived from primary BRK cells by transformation with an E1A plus tsp53 (val135) Figure 3 Characterization of the binding ability of rBax-BH3Bcl2 and hBcl2-BH3Bax in yeast. (a) The binding activity of two chimeras to hBcl-2, E1B 19K, rBax, and hNbk. Strong interaction is indicated by (+++), very weak interaction by (+/7), and no interaction by (7). The combination of pGBT-9-rBax and pGAD-rBax was toxic to YGH1, as indicated by few colonies on +histidine plates. (b) Photograph of each combination on +histidine and 7histidine plates (Debbas and White, 1993) . Twenty-four hours posttransfection, a b-gal assay was performed to measure the viability of the transfected cells. The level of BaxBH3Bcl2 expression was similar to that of Bax. However, the expression level of Bcl2-BH3Bax protein was much lower than that of Bax or Bcl-2 (data not shown). It is possible that this lower expression level of Bcl2-BH3Bax would prevent function of Bcl2-BH3Bax. However, Bcl2-BH3Bax did antagonize E1B 19K function (Figure 8 ), indicating that functional activity was detectable even with low levels of expression. Ectopic expression of rBax in the p53A cell line at the restrictive temperature induced massive apoptosis as indicated by the low percentage of blue cells ( Figure  6a ) (Han et al., 1996a) . Although transient Bcl-2 expression was partially toxic as indicated by reduced viability compared to the vector control, survival was dramatically greater than that conferred by transient Bax expression (Figure 6a ). Ectopic expression of rBaxBH3Bcl2 displayed equal killing activity to rBax ( Figure 6a ). However, the ectopic expression of the hBcl2-BH3Bax protein did not change the percentage of blue cells compared to wild-type hBcl-2. Therefore, exchanging the BH3 region of rBax with that of hBcl-2 preserved pro-apoptotic activity of rBax. However, the BH3 region of rBax was insucient to confer proapoptotic activity to Bcl-2.
hBcl-2 but not hBcl2-BH3Bax can block p53-induced apoptosis
We have demonstrated that Bcl-2, like E1B 19K, can block E1A-induced, p53-mediated apoptosis (Chiou et al., 1994a) . We generated stable cell lines expressing hBcl2-BH3Bax in p53A in order to check the possibility that hBcl2-BH3Bax can abrogate E1A-induced, p53-mediated apoptosis. The pcDNA3-MychBcl2-BH3Bax plasmid was transfected into the p53A cells at the restrictive temperature and incubated in neomycin-containing medium. Two independently derived cell lines (hBcl2-BH3Bax-1 and hBcl2-BH3Bax-2), which stably expressed the hBcl2-BH3Bax protein (Figure 6b ), were then incubated at the permissive temperature to determine whether the expression of the hBcl2-BH3Bax protein could block E1A-induced, p53-mediated apoptosis.
The percentage of viable cells did not appear to signi®cantly dier from the control Neo cell line, whereas p53A derived cell lines stably expressing Bcl-2 remained viable (Figure 6c ). Therefore, hBcl2-BH3Bax cannot abrogate E1A-induced, p53-mediated apoptosis, indicating that hBcl2-BH3Bax does not have death-suppressing activity like hBcl-2. Thus, replacing BH3 of Bcl-2 with that of Bax generated a chimeric protein which neither induced or suppressed apoptosis. In vitro binding assay of the two Bax-Bcl2 chimeras with E1B 19K and hBcl-2. (a) Production and purity of the GSTfusion proteins. GST, GST-19K, and GST-Bcl-2 which does not have transmembrane region (13 amino acids), were produced in BL21 and puri®ed on glutathione sepharose beads. The quantity and purity were evaluated by SDS ± PAGE. (b) GST-fusion protein assay for rBax and rBax-BH3Bcl2 interaction with 19K and hBcl-2. The GST-fusion proteins (GST, were incubated with the in vitro-translated rBax and rBaxBH3Bcl2 in the buer (50 mM Tris [pH 7.5], 150 mM NaCl, and 0.2% NP-40) for 2 h at 48C and recovered on glutathione sepharose beads. The precipitated beads were analysed by SDS ± PAGE. (c) GST-fusion protein assay for hBcl-2 and hBcl2-BH3Bax interaction with 19K and hBcl-2. This assay used the same condition as described in (b) Figure 5 Intracellular localization of the rBax, rBax-BH3Bcl2, hBcl-2, and hBcl2-BH3Bax proteins. The 4B cell line was transfected with rBax, rBax-BH3Bcl2, hBcl-2, or hBcl2-BH3Bax. Sixteen hours post-transfection, the transfected cells were ®xed and stained with an anti-Myc monoclonal antibody directed against the Myc epitope tag
The biological role of BH3 J Han et al E1B 19K can antagonize the pro-apoptotic function of rBax but not rBax-BH3Bcl2
We have demonstrated previously that the expression of the E1B 19K protein binds to and antagonizes the apoptotic function of the rBax protein (Han et al., 1996a) . Therefore, the direct interaction of the E1B 19K protein with rBax may be required to antagonize rBax-induced apoptosis. However, recent data suggests that the direct interaction of Bcl-x L with Bax is not required for Bcl-x L to exert its death-suppressing activity (Cheng et al., 1996) , and that Bax does not require heterodimerization with Bcl-x L to counter the death suppressing activity of Bcl-x L (Simonian et al., 1996) . These data suggest that direct interaction may not be required for Bcl-2 family members to function as death inducers or death repressors. Based on the observation that rBax-BH3Bcl2 did not interact with E1B 19K but induced cell death, rBax-BH3Bcl2 and E1B 19K were contransfected into the p53A cells to determine whether the E1B 19K protein can antagonize rBax-BH3Bcl2-induced cell death (Figure 7 ). Whereas E1B 19K expression eciently antagonized cell killing by rBax, it failed to antagonize cell killing by rBaxBH3Bcl2 ( Figure 7) . Therefore, the ability of E1B 19K to bind to rBax directly correlated with the ability to abrogate rBax-induced apoptosis. This suggests that E1B 19K may act as an antagonizer of apoptosis rather than as an eector of cell survival.
hBcl2-BH3Bax can antagonize anti-apoptotic function of E1B 19K
Even though hBcl2-BH3Bax could neither induce cell death nor block E1A-induced, p53-mediated apoptosis (Figure 6a and c), hBcl2-BH3Bax speci®cally interacted with E1B 19K, but not hBcl-2, rBax, and hNbk ( Figure 3 ). We used this characteristic of hBcl2-BH3Bax and transiently expressed the hBcl2-BH3Bax protein in the 19K1 and 4B cell lines (Chiou et al., 1994a; Debbas and White, 1993) to test whether hBcl2-BH3Bax could act as an antagonizer of E1B 19K or hBcl-2. The 19K1 and 4B cell lines are resistant to apoptosis at the permissive temperature since the expression of the E1B 19K and Bcl-2 proteins block E1A-induced, p53-mediated apoptosis (Chiou et al., 1994a; Debbas and White, 1993) .
The hBcl2-BH3Bax expression plasmid was cotransfected with pCMVb-gal into the 19K1 and 4B cell lines at the restrictive temperature (Figure 8) . At 24 h post- Figure 6 Regulation of apoptosis by rBax-BH3Bcl2 and hBcl2-BH3Bax. (a) rBax-BH3Bcl2 induced apoptosis in BRK cells. Vector alone, pcDNA3-Myc-hBcl-2, pcDNA3-19K, pcDNA3-Myc-rBax, pcDNA3-Myc-rBax-BH3Bcl2 or pcDNA3-MychBcl2-BH3Bax was cotransfected with pCMVb-gal at a 1 : 3 ratio into p53A cells, the E1A plus tsp53 (val135) transformed BRK cell line. The transfected cells were incubated at 38.58C for 24 h after transfection. A b-gal assay was performed and the percentage of blue viable cells was determined. (b) Expression of the hBcl2-BH3Bax protein in hBcl2-BH3Bax-1 and hBcl2-BH3Bax-2 stable cell lines. Whole cell extracts were prepared from the hBcl2-BH3Bax-1 and hBcl2-BH3Bax-2 cell lines. Twenty-®ve mg of whole cell extract from each cell line was subjected to SDS ± PAGE, transferred to nitrocellulose, and probed with an anti-Myc monoclonal antibody to detect hBcl2-BH3Bax chimeric protein. (c) hBcl2-BH3Bax did not inhibit E1A-induced, p53-mediated cell death. The stable cell lines of hBcl2-BH3Bax-1 and hBcl2-BH3Bax-2 were incubated at the permissive temperature (328C) and cell viability was determined from day 1 to day 4 by trypan blue exclusion transfection, the transfected cells were shifted to the permissive temperature and 48 h later, the percentage of blue cells was determined by a b-gal assay. Whereas control transfected 19K1 cells remained viable, the transient expression of the hBcl2-BH3Bax protein in the 19K1 cells at the permissive temperature caused extensive cell death, similar to rBax or rBax-BH3Bcl2 (Figure 8) . However, the expression of hBcl2-BH3Bax in the 4B cell line did not induce cell death when compared to the vector alone (Figure 8 ). Since hBcl2-BH3Bax has no detectable activity on its own, it may antagonize E1B 19K function in the 19K1 cell line, via a direct protein ± protein interaction.
rBax and rBax-BH3Bcl2, but not 19K or hNbk, localize to mitochondria E1B 19K, rBax, rBax-BH3Bcl2, and hNbk were transfected into COS cells to determine whether rBax, rBax-BH3Bcl2, and hNbk are localized in the mitochondria, and whether the coexpression of the E1B 19K protein, which is not normally found in mitochondria (White et al., 1984; White and Cipriani, 1989, 1990) , alters their localization. Four hours posttransfection, a caspase inhibitor, Z-VAD.FMK, was added into the medium to block rBax-, rBax-BH3Bcl2-and hNbk-induced apoptosis. Twenty hours posttransfection, the cells were stained with the mitochondrial staining dye, MitoTracker, to evaluate the disturbances in mitochondrial membrane potential, and ®xed to determine the localization of the ectopically expressed proteins. Identical results were obtained with transfected BRK and HeLa cells as well as COS cells, but because of the higher quality of the photographs, only data from COS cells are shown.
The E1B 19K protein was localized in nuclear envelope, as well as cytoplasmic membranes and the cytoskeleton, typi®ed by bright punctate cytoplasmic staining (White et al., 1984; White and Cipriani, 1989, 1990) (Figure 9a-2) . The E1B 19K staining pattern was distinct from that of mitochondria, consistent with previous reports of its localization (Figure 9a) . In contrast to the E1B 19K protein, the rBax protein was localized in and around mitochondria (Figure 9b-3) . The colocalization of Bax and mitochondria was more obvious in cells with less Bax expression (data not shown). Interestingly, the mitochondrial staining was either dramatically reduced or was absent in more than 98 per cent of Bax-expressing cells (Figure 9b-1 ) (Wolter et al., 1997) , suggesting that the expression of the rBax protein resulted in the loss of the mitochondrial membrane potential. The rBaxBH3Bcl2 protein showed the same localization (Figure 9c-3 ) and mitochondrial staining pattern in most of Bax-BH3Bcl2-expressing cells (Figure 9c-1) as the rBax protein, suggesting that BH3 of hBcl-2 did not aect the function or localization of rBaxBH3Bcl2.
In contrast to rBax and rBax-BH3Bcl2, hNbk protein was localized around the nucleus and was distributed in cytoplasm in the pattern distinct from mitochondria (Figure 9d-3) . None-the-less the mitochondrial staining was either reduced or absent in about 95 per cent of Nbk-transfected cells (Figure 9d-1) . Therefore, expression of rBax, rBax-BH3Bcl2, and hNbk, which are all death inducers, shared a common ability to cause a signi®cant decrease in the mitochondrial membrane potential. This loss of mitochondrial membrane potential occurred in the presence of Z-VAD.FMK (Figure 9b, c, and d) , suggesting that it may occur by a caspase-independent mechanism (Shimizu et al., 1996) . The rBax and rBax-BH3Bcl2 proteins localized to mitochondria, suggesting that they function in, or close to, mitochondria. Alternatively, Figure 8 hBcl2-BH3Bax antagonizes the survival function of E1B 19K but not Bcl-2. Twenty mg of pcDNA3-Myc-hBcl2-BH3Bax was contransfected with 2 mg of pCMVb-gal into the E1B 19K expressing 19K1 cell line or the Bcl-2 expressing 4B cell line at the restrictive temperature. The transfected cells were shifted to the permissive temperature 24 h after transfection. Forty-eight hours after the temperature-shift, the percentage of blue viable cells was determined The biological role of BH3 J Han et al hNbk, which has only BH3 and otherwise does not possess sequence homology to Bcl-2 family members, appears to have the ability to cause a loss of mitochondrial membrane potential without direct localization to mitochondria. Since hNbk binds speci®cally to anti-apoptotic proteins, it may function indirectly to induce cell death by antagonizing a prosurvival activity.
Reciprocal alterations in the localization of pro-and anti-apoptotic proteins
Whereas rBax localized to mitochondria and E1B 19K did not, coexpression of E1B 19K with rBax substantially diverted the localization of E1B 19K to mitochondria (Figure 10a) . Similar results were obtained with Bax and E1B 19K staining in absence of mitotracker (Han et al., 1996a) . Also, the coexpression changed the localization of rBax to that of E1B 19K (data not shown), suggesting that E1B 19K can additionally inhibit rBax outside of mitochondria. Coexpression of E1B 19K and rBax also restored the mitochondrial membrane potential as indicated by bright mitochondrial staining (Figure 10a ± 1) . Coexpression of E1B 19K and Bax-BH3Bcl2 results in a localization pattern that largely overlapped ( Figure  10b) . However, the localization pattern of BaxBH3Bcl2 was more punctate than E1B 19K. In contrast, mitochondrial staining was greatly diminished even when E1B 19K was coexpressed with the rBax-BH3Bcl2 protein (Figure 10e-1) . hNbk colocalized with the E1B 19K protein (Figure 10d ) and the mitochondrial membrane potential was maintained (Figure 10d ± 1) . These data indicate that E1B 19K may antagonize hNbk by direct interaction, resulting in recovery of mitochondrial membrane potential.
Discussion
To address the biological role of BH3 in Bcl-2 family members, we exchanged BH3 between rBax and hBcl- In contrast to what is seen with wild-type rBax, rBax-BH3Bcl2 did not interact with E1B 19K, but was still capable of inducing apoptosis. E1B 19K expression failed to antagonize the pro-apoptotic activity of rBaxBH3Bcl2, implying that direct interaction between E1B 19K and rBax was required to inhibit apoptosis. Replacing BH3 in hBcl-2 with BH3 of rBax conferred on Bcl-2 the ability to bind to E1B 19K. Although hBcl2-BH3Bax did not have any detectable ability to induce or inhibit apoptosis on its own, it could antagonize the function of E1B 19K and induce cell death. Thus, these data suggest that antagonization by direct protein-protein interaction could suppress the survival promoting activity (Figure 11) . It has been shown that replacement of Bcl-2 amino acids 77 ± 116 with Bax amino acids 55 ± 77 converts Bcl-2 from an inhibitor into an activator of cell death (Hunter and Parslow, 1996) . However, our Bcl2-BH3Bax does not have any pro-or anti-apoptotic property. One possible explanation for this discrepancy is that Bcl2-BH3Bax does not interact with Bax, Bcl-2, and Nbk, thus, it cannot antagonize other Bcl-2 family members. Unfortunately, the capacity of Bcl-2 with 77 ± 116 amino acids exchanged with 55 ± 77 amino acids of Bax to bind to other Bcl-2 family members was not determined (Hunter and Parslow, 1996) , which makes correlating binding with function dicult. Our speculation is that insertion of part of Bax could aect the binding ability or speci®city of the Bcl2-BH3Bax chimeric protein, which leads to a change of functional activity, or that the insertion causes a vast conformational change and results in a complete loss of functional activity.
It has remained controversial as to which components among Bcl-2 family members are eectors in modulating the apoptotic process. If a pro-apoptotic Bcl-2 homologue such as Bax acts as an eector of cell death, an anti-apoptotic Bcl-2 homologue such as Bcl-2 or E1B 19K may merely inhibit the pro-apoptotic function. Conversely, if an anti-apoptotic Bcl-2 homologue functions as a survival eector, then a proapoptotic Bcl-2 homologue may merely block its A third scenario would be a dual eector model whereby eectors of survival and death exist and apoptosis is regulated by mutual antagonism. In support of the ®rst hypothesis, mutant Bax, which cannot interact with Bcl-2, can still induce cell death mediated by chemotherapeutic drugs (Simonian et al., 1996) . In contrast, speci®c mutants that disrupt the ability of Bcl-x L to interact with Bax or Bak, still display the death-suppressing activity (Cheng et al., 1996) . Possibly, these two contradictory observations can be reconciled by the dual eector model, such that proapoptotic Bcl-2 homologues are death eectors whereas anti-apoptotic Bcl-2 homologues are survival eectors. The present studies indicated that E1B 19K, the anti-apoptotic adenoviral Bcl-2 homologue, could not abrogate rBax-induced apoptosis without a direct protein-protein interaction with Bax ( Figure 11 ). This result is supported by mutational analysis of E1B 19K where loss of Bax binding ability results in loss of survival activity (Chen et al., 1996; Chiou et al., 1994b; Han et al., 1996a) . Taken together, this suggests that E1B 19K may not be a survival eector, but rather may antagonize death induction by rBax. Bax, in turn, interacts with Bcl-2 and could antagonize the survival function of Bcl-2. However, Bax also has membrane ion channel-forming ability (Antonsson et al., 1997) , which implicates Bax as a death eector. This same situation can be said for Bcl-2. Bcl-2 binds to Bax, but has membrane ion channel-forming ability, suggesting that Bcl-2 could be a survival eector (Reed, 1997; Schendel et al., 1997) . Nbk/Bik is a member of Bcl-2 family, which has only BH3, and otherwise is not homologous to Bcl-2-related proteins. Based on the lack of mitochondria localization of Nbk (Figures 9  and 10) , it may antagonize survival eector molecules through BH3 rather than act as an eector of apoptosis. Taken together, Bcl-2 family members can be divided into four categories, eectors of death such as Bax, eectors of survival such as Bcl-2, antagonizers of death such as E1B 19K, and antagonizers of survival such as Nbk (Figure 11 ). E1B 19K interacts with Bax via BH3, but not with Bcl-2 which also has BH3. Possible explanations for this binding speci®city are that a domain unique to Bcl-2, for example BH4, may inhibit the binding of BH3 of Bcl-2 to E1B 19K, or that the dierence in binding speci®city is conferred by BH3. The later explanation appears to be the case. Nbk contains BH3, and binds to Bcl-2 and E1B 19K, but not Bax, which indicates that BH3 confers binding speci®city. Another example is represented by rBax-BH3Bcl2 which, unlike wild-type rBax, does not interact with E1B 19K. This exchange of BH3 in Bax with that of Bcl-2 did not alter the pro-apoptotic function of Bax as demonstrated by the dramatic killing eect. These data argue against the possibility that BH3 of rBax or Bcl-2 may contain a pro-apoptotic or an anti-apoptotic property, respectively. It is more likely that BH3 contributes to binding speci®city among Bcl-2 family members and that regulation of apoptosis takes place at the level of protein-protein interactions between the family members in combination with survival and death eector activity.
Evidence suggests that some Bcl-2 family members are localized in the outer membrane of mitochondria (Gonzalez-Garcia et al., 1994; Krajewski et al., 1994; Zha et al., 1996) . Furthermore, induction of apoptosis results in a loss of membrane potential (Vander Heiden et al., 1997) . We have demonstrated that the expression of the rBax protein results in colocalization with mitochondria and a signi®cant reduction of mitochondrial staining, suggesting that rBax could aect the mitochondrial membrane potential, which is blocked by E1B 19K interaction with Bax. Similar results (Wolter et al., 1997) have indicated that in the presence of an apoptotic stimulus, Bax localization diverts from the cytoplasm to the mitochondria which is accompanied by a reduction in the mitochondrial staining. In this situation, mitochondria are unable to perform the respiratory function and rBax-expressing cells may eventually die from the lack of energy. In perhaps a redundant mechanism to induce cell death, expression Figure 11 Model for regulation of apoptosis by Bcl-2 family members. BH3 contributes to the binding speci®city of Bcl-2 family members. E1B 19K blocks rBax-and hNbk-induced loss of mitochondrial membrane potential and apoptosis. However, it does not prevent rBax-BH3Bcl2-induced loss of mitochondrial membrane potential and apoptosis, indicating that direct interaction between E1B 19K and pro-apoptotic proteins is required for E1B 19K to display anti-apoptotic activity. This model also suggests that Bax may be an eector of death, and E1B 19K and Nbk may act as antagonizers of death and survival, respectively of rBax may allow the release of mitochondrial components including cytochrome c, which in turn activates caspases to promote apoptosis (Li et al., 1997) . Our studies indicate that the coexpression of the E1B 19K with rBax, however, may rescue the loss of membrane potential by sequestering the rBax protein and/or inactivating its function. We demonstrate that direct interaction of E1B 19K with Bax is required for E1B 19K to inhibit the rBax-induced loss of mitochondrial membrane potential since rBaxBH3Bcl2, which is resistant to E1B 19K binding, profoundly decreases mitochondrial staining.
Endogenous Bax is reported to be cytosolic and only recruited to mitochondria upon delivery of an apoptotic stimulus (Wolter et al., 1997) . Transiently expressed Bax located to mitochondria (Figure 8 ). Whether this is due to introduction of a death stimulus by transfection or cell type speci®c dierence has not been determined.
The mechanism by which rBax causes a loss of mitochondrial membrane potential remains unclear. It is possible that rBax could antagonize death-suppressing Bcl-2 homologues located in mitochondria. Alternatively, rBax could disrupt mitochondrial membrane potential by producing pores in the outer membrane. It is interesting that the presence of Z-VAD.FMK cannot block the rBax-induced loss of mitochondrial membrane potential. This suggests that caspases are activated after the loss of mitochondrial membrane potential (Kaushal et al., 1997; Kim et al., 1997; Shimizu et al., 1996) . However, the loss of mitochondrial membrane potential may be not the only mechanism for activating caspases (De Maria et al., 1997) nor the only mechanism for induction of cell death. Failure to maintain mitochondrial membrane potential may induce cell death in the absence of caspase activity.
The results of this study demonstrate that BH3 determines the binding speci®city of Bcl-2 family members and that E1B 19K prevents rBax-induced apoptosis through a direct interaction with Bax via BH3. The data also suggest that Bax and Bcl-2 may be eectors of survival and death, and that E1B 19K and Nbk may be antagonizers of death and survival, respectively.
Materials and methods
Generation of Bax-Bc12 chimeras
To generate the rat Bax-BH3Bcl2 clone, special primers were designed, which partially encode rBax sequence and human Bcl-2 sequence in the swapped region (BH3) (Figure 2b ). Capital letters in the sequence of the primers represent rBax sequence whereas lower case letters represent hBcl-2 sequence. The ®rst N-terminal fragment of rBax-BH3Bcl2 was generated by PCR with rBax 5' primer (5'-TAA TAC CCG GGT ATG GAC GGG TCC GGG GAG C-3') which has a start codon and XmaI site, and the ®rst 3' primer of rBax-BH3Bcl2 which has the rBax sequence just before the swapped region and part of the swapped region in rBax-BH3Bcl2 (5'-gga gaa gtc gtc gcc ggc ttg ccg gag ACA CTC GCT CAG CTT CTT GGT GG-3'). We also made the ®rst C-terminal fragment of rBax-BH3Bc12 with rBax 3' primer (5' -CGC TGC-TCG AGT CAG CCC ATC TTC TTC CAG AT-3') which has a stop codon and XhoI site, and the ®rst 5' primer of rBax-BH3Bcl2 which has the rBax sequence of just after the swapped region and the swapped region in rBaxBH3Bcl2 (5'-gac ttc tcc cgc cgc tac cgc CTG CAG AG-G ATG ATT GCT GAC GAC-3'). We used the ®rst Nterminal fragment of rBax-BH3Bcl2 as a template, and the rBax 5' primer which has a start codon and XmaI site, and the second 3' primer of rBax-BH3Bcl2
(5'-AT CCT CTG CAG gcg gta gcg gcg gga gaa gtc gtc gcc ggc ttg ccg ga-3') which has more extended swapped sequence than the ®rst 3' primer sequence of rBaxBH3Bcl2. This produced a longer second N-terminal fragment of rBax-BH3Bcl2 than the original ®rst 5' fragment of rBax-BH3Bcl2. The second N-terminal DNA fragment and the ®rst C-terminal DNA fragment were used as templates, and the rBax 5' primer and rBax 3' primer were used to generate the full length rBax-BH3Bcl2 clone.
We performed the same technique for generating rBcl2-BH3Bax using hBcl2 clone as a template, and 5' (5'-gcatt gaattc a atg gcg cac gct ggg aga aca-3'), 3' (5'-tcacg ctcgag tca ctt gtg gct cag ata-3') primers for hBcl-2 and the ®rst hBcl2-BH3Bax 3' primer (5'-T GTC CAG TTC ATC TCC AAT TCG GCG GAG ggc cag gtg gac cac agg tgg c-3'), the second hBcl2-BH3Bax 3' primer (5'-tc ggc gaa gtc gcc CTC CAT ATT GCT GTC CAG TTC ATC TCC AAT TCG GC-3'), and the ®rst hBcl2-BH3Bax 5' Primer (5'-A GAT GAA CTG GAC AGC AAT ATG GAG cgc gac ttc gcc gag atg tcc agc c-3'). The sequence of the two BaxBcl2 chimeras was con®rmed by standard sequencing using Sequenase 2 kit in both strands (United States Biochemical Corp., Cleveland, OH, USA). Both of the Bax-Bcl2 chimeras were inserted into pGAD vector and pcDNA3 vector for further analysis.
Plasmid construction
To generate the deletion mutants (rBax 50 ± 61, rBax 59 ± 69, rBax 63 ± 72, rBax 70 ± 78, rBax 63 ± 75, rBax 50 ± 74, rBax 54 ± 78 and rBax 54 ± 66) of part of the exon 3 region of rBax, which is the binding region of rBax with E1B 19K and hBcl2 in yeast, we used the technique of annealing long oligomers. We designed each oligomer of sense and antisense strands, with an EcoRI site at 5' end and XhoI site at 3' end. One hundred pmol of each oligomer was added into 20 ml of H 2 O. Temperature was increased to 928C and cooled down slowly for 2 h to 358C. Two ml of the annealed oligomers was used for ligation into the pGAD vector, using EcoRI and XhoI sites. E1B 19K in pGBT9 and hBcl-2 in pGBT8 were previously described (Han et al., 1996a) . rBax in pGBT9 and human Nbk/Bik in pGBT9 were generated by standard PCR techniques. rBax in pGBT9 was cloned in EcoRI and BamHI sites, and hNbk in pGBT9 was cloned in EcoRI and PstI sites in reading frame of DNA binding domain of gal4 protein. rBax-BH3Bcl2 in pGAD and hBc12-BH3Bax in pGAD were cloned in XmaI and XhoI, and EcoRI and XhoI, respectively. E1B 19K in pGEX4T-1 was previously described (Han et al., 1996a) . hBcl-2 in pGEX4T-3 was cloned by standard PCR methods using EcoRI and XhoI sites without transmembrane region of hBcl-2 at the C-terminus (D13 amino acids).
To generate mammalian expression constructs, we used pcDNA3 vector which has a CMV promoter as well as a T7 promoter for in vitro protein production. pcDNA3-MycrBax, pcDNA3-E1B 19K, and pcDNA3-Myc-hNbk were described previously (Han et al., 1996a, b) . hBcl2 was cloned in pcDNA3 with a Myc epitope tag at N-terminus using EcoRI and XhoI sites. Also, Bax-BH3Bcl2 and Bcl2-BH3Bax were cloned into pcDNA3 with a myc epitope tag at Nterminus using XmaI and XhoI, and EcoRI and XhoI sites, respectively. The sequence of the constructs we generated was con®rmed using an ABI PRISM 377 automated DNA sequencer (The Perkin-Elmer corporation, Foster City, CA, USA).
Two-hybrid system
The YGH1 strain (ura3 ± 25, his3 ± 200, ade2 ± 101, lys-2 ± 801, trp1 ± 901, leu2 ± 3, Can r , gal4 ± 542, gal80 ± 538, LYS2::gal1 uas -gal1 tata -HIS3, URA3::gal1-lacZ) (Hannon et al., 1993) was used for analysis of binding ability for each combination as described previously. Transformations were performed by the lithium acetate method, using 4 mg of plasmid DNA and 20 mg of sheared, denatured salmon sperm DNA. Transformants were plated on yeast drop-out plates lacking leucine, tryptophan and histidine. Transformants were selected by growth in the absence of histidine and assayed for b-galactosidase activity, as a second reporter using a ®lter based assay (Hannon et al., 1993) .
In vitro protein interaction assays
For GST fusion protein binding assays, BL21 DE3 was transformed with pGEX4T-1-19K and pGEX4T-3-hBcl-2 plasmids and induced with 0.5 mM of isopropyl-b-Dthiogalactoside. A 100 ml aliquot of culture was analysed by SDS ± PAGE to evaluate the induction of fusion protein. The remaining culture was sonicated on ice by 7 short bursts for 4 s (Fischer Sonic Dismembranator 3000), clari®ed by centrifugation and the supernatant was mixed with 50% v/v glutathione sepharose beads (Pharmacia Biotech, Piscataway, NJ, USA). An aliquot of the protein bound beads was analysed by SDS ± PAGE to ensure equal amounts of the pure fusion proteins were present.
In vitro binding assays were performed by incubating equal amounts of GST, GST-19K, and GST-hBcl-2 (3 mg), immobilized onto glutathione sepharose beads, with in vitro translated rBax, rBax-BH3Bcl2, hBcl-2 or hBcl2-BH3Bax proteins diluted in 0.5 ml of buer (50 mM Tris [pH 7.5], 150 mM NaCl and 0.2% NP-40). The mixture was incubated for 2 h at 48C, washed three times with the buer and resuspended in 26Laemmli Buer. All samples were boiled for 5 min and the proteins were resolved by 15% SDS ± PAGE. Gels were ®xed in 50% methanol and 10% glacial acetic acid for 2 h and dried.
Cell lines
The p53A, 19K1 and 4B cell lines have been described previously (Chiou et al., 1994a; Debbas and White, 1993) . The p53A cell line was derived from primary BRK cells that were transfected with genes encoding adenovirus E1A and the murine temperature-sensitive p53 (val135), which is predominantly in the mutant conformation at the restrictive temperature of 38.58C and predominantly in the wild-type conformation at the permissive temperature of 328C (Michalovitz et al., 1990) . The p53A cell line is transformed and proliferates at the restrictive temperature of 38.58C but undergoes apoptosis rapidly upon incubation at the permissive temperature for wild-type p53 (Debbas and White, 1993) . The 19K1 cell line was derived from the p53A cell line and stably expresses the adenovirus E1B 19K protein (Debbas and White, 1993) . The 19K1 cell line is protected from p53-mediated apoptosis at the permissive temperature and instead undergoes p53-mediated growth arrest (Sabbatini et al., 1995) . The 4B cell line was also derived from p53A cell line and stably expresses the human Bcl-2 (Chiou et al., 1994a) . The 4B cell line, like the 19K1 cell line, is protected from p53-mediated apoptosis and undergoes p53-mediated growth arrest at the permissive temperature (Chiou et al., 1994b) . The Bcl2-BH3Bax cell line was generated from p53A cell line. The p53A cell line was transfected with 0.5 and 1 mg of linerized the pcDNA3-Myc-hBcl2-BH3Bax plasmid by electroporation. Stable cell lines were maintained at 38.58C and selected by neomycin resistance (1 mg/ml) and 24 independent cell clones were isolated and expanded. Neomycin resistant clones were screened for the expression of the hBcl2-BH3Bax protein by conventional Western blotting analysis using an antiMyc monoclonal antibody.
Indirect immuno¯uorescence and mitochondria staining 4B, the E1A plus tsp53 (val135) transformed BRK cell line that expresses the human Bcl2 protein (Chiou et al., 1994a) , was plated at 90% con¯uence at the restrictive temperature (38.58C). The 4B cell line was electroporated with 10 mg of the pcDNA3-Myc-rBax, pcDNA3-Myc-rBaxBH3Bcl2, pcDNA3-Myc-hBcl-2, or pcDNA3-Myc-hBcl2-BH3Bax. Cells were ®xed with methanol 24 h posttransfection and labeled with an anti-Myc monoclonal antibody (Oncogene Science, Inc., Cambridge, MA, USA) at 1 : 5 dilution. Antibodies were visualized with goat antimouse rhodamine conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA).
MitoTracker was utilized for staining mitochondria (Molecular Probes Inc., Eugene, OR, USA). COS, BRK and HeLa cells grown on coverslips were transfected with 10 mg of plasmid. Three hundred mM of Z-VAD.FMK (Enzyme System Products, Dublin, CA, USA) was added 4 h post-transfection and 400 nM of MitoTracker was added into media 20 h post-transfection. After a 30 min incubation with MitoTracker, the transfected cells were ®xed with 3.7% of paraformaldehyde and incubated for 15 min at 378C followed by ice-cold acetone for 10 min. The ®xed and permeabilized cells were double-labeled with an anti-Myc monoclonal antibody at 1 : 5 dilution and an anti-19K polyclonal antibody (p21) (White and Cipriani, 1989 ) at a 1 : 200 dilution. Antibodies were visualized with goat antimouse aminomethylcoumarin acetate (AMCA)-conjugated and goat anti-rabbit¯uorescein-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA).
Functional assays
To examine rBax-BH3Bcl2 and hBcl2-BH3Bax function in transient expression assays, 6 mg of pcDNA3-Myc-rBaxBH3Bcl2 or 6 mg of pcDNA3-Myc-hBcl2-BH3Bax were cotransfected with 2 mg of pCMVb-gal plasmid expressing b-galactosidase for the cytomegalovirus promoter into the p53A cell line at 38.58C by electroporation as described previously (Debbas and White, 1993) . Twenty-four hours after transfection, the percentage of blue viable cells was determined as described previously (Han et al., 1996b) .
To determine whether hBcl2-BH3Bax has a survival function as does wild-type hBcl2, a hBcl2-BH3Bax expressing stable cell line was generated from p53A cell line. Two independently derived clones were shifted down to the permissive temperature (328C) and cell viability was determined from day 1 to day 4 by trypan blue exclusion.
To see whether E1B 19K can antagonize rBax-BH3Bcl2-induced apoptosis, the cotransfection of pcDNA3-E1B 19K and pcDNA3-Myc-rBax-BH3Bcl2 plasmids was performed in the p53A cell line. The amount of the transfected pcDNA3-Myc-rBax-BH3Bcl2 plasmid and pCMVb-gal plasmid was ®xed at 6 mg and 2 mg respectively, and two plasmid were cotransfected with 0 mg, 10 mg and 20 mg of the control vector or the pcDNA3-E1B 19K plasmid. Thirty-six hours post-transfection, the percentage of blue viable cells were determined as described. To test whether hBcl2-BH3Bax can antagonize the E1B 19K function based on its binding ability, 15 mg of the pcDNA3-Myc-hBcl2-BH3Bax plasmid was cotransfected with 2 mg of the pCMVb-gal plasmid into the 19K1 and 4B cell lines. Twenty-four hours post-transfection the transfected cells were shifted down to 328C. Forty-eight hours after temperature shift, the percentage of blue viable cells were determined as described.
Western blotting
Cell extracts for Western blot analysis were prepared from subcon¯uent cultures, and 25 mg of protein from each cell line was analysed by SDS ± PAGE and semidry blotting onto nitrocellulose membranes by standard procedures. Immune complexes were detected by enhanced chemiluminescence (ECL) according to the manufacturer's specifications (Amersham Corp., Arlington, IL, USA).
